Notably, tumor sample analysis showed that RB1 protein abundance was slightly increased, while protein levels of CDK6, cyclin D3, cyclin E1, cyclin D1, SKP2, and CDK2 were significantly decreased in the combination treatment group (Fig. 7i). The gene discussed is CCND1; the disease is neoplasm.